ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 110

Consequences and Predictors of Persisting Pain in Children with Juvenile Idiopathic Arthritis: A Case Control Study Nested in the ReACCh-Out Cohort

Tara McGrath1, Jaime Guzman 2, Lori Tucker 3, Natalie Shiff 4, Maryna Yaskina 5, Susan Tupper 6 and Dax Rumsey 7, 1University of British Columbia, Vancouver, Canada, 2University of British Columbia and BC Children's Hospital, Vancouver, Canada, 3BC Children's Hospital, Vancouver, British Columbia, Canada, 4Florida, Gainesville, 5Women and Children's Research Institute, Edmonton, Canada, 6Saskatoon, Canada, 7University of Alberta, Edmonton, Canada

Meeting: 2020 Pediatric Rheumatology Symposium

Keywords: child, Chronic pain, Enthesitis, juvenile idiopathic arthritis (JIA), pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.

Date: Friday, May 1, 2020

Title: Poster Session 2

Session Type: ACR Abstract Session

Session Time: 5:00PM-6:00PM

Background/Purpose: Juvenile Idiopathic Arthritis (JIA) is the most common rheumatic disease of childhood. Pain is a distressing and prevalent feature of JIA and can decrease children’s quality of life. Identifying predictors of persisting pain in children with JIA will enable health care providers to better target pain management.

The purpose of this study is to describe consequences and predictors of persisting pain in children with Juvenile Idiopathic Arthritis (JIA).

Methods: The ReACCH-Out cohort consists of approximately 1500 children followed for up to 5 years.  In this case-control study, we compared JIA cases of ‘moderate-to-severe persisting pain’ (31 patients) with JIA controls of ‘moderate-to-severe decreasing pain’ (118 patients). Moderate-to-severe pain was defined as > 3.5 cm using a Visual Analogue Scale (VAS). Follow-up was minimum 3 years.  Cases were compared to controls using linear mixed models to assess the impact of pain on function, quality of life, and parent and physician global assessments over time. Logistic regression was performed to examine the association between each of the following potential baseline predictors with persisting pain: age at onset, sex, JIA category at baseline, enthesitis at baseline, and active joint count at baseline.

Results: A 1 cm increase in pain intensity was associated with an increase of 0.13 units in Childhood Health Assessment Questionnaire (CHAQ) disability index (CI 95% 0.11-0.14), 0.33 in Juvenile Arthritis Quality of Life Questionnaire (JAQQ) (0.31-0.36), 0.19 in JAQQ psychosocial (0.16-0.22), 0.62 in Parent Global (0.58-0.66), and 0.44 in Physician Global (0.40-0.49) scores; and with a 0.32 units decrease in the Quality of My Life (QoML) score (0.37-0.28). In the final multivariate regression model, enthesitis count at baseline (OR 1.40, CI 95% 1.19-1.76), female sex (4.14, 1.33-16.83) and the overall QoML baseline score (0.82, 0.69-0.98) predicted development of persisting pain.

Conclusion: Among children with JIA with moderate-to-severe pain at baseline, pain intensity was strongly related to function, quality of life and parent and physician global scores while female sex, lower overall quality of life, and higher enthesitis counts at baseline predicted development of persistent pain.

Figure 1: Change in Median Pain Scores over time in Cases and Controls. Legend: The length of the box represents the interquartile range (IQR). The circles within the box represent the group mean and the horizontal line within the box represents the group median. The whiskers are drawn to the most extreme points in the group that lie within the fences. The upper fence is defined as the third quartile (represented by the upper edge of the box) plus 1.5 times the interquartile range (IQR). The lower fence is defined as the first quartile (represented by the lower edge of the box) minus 1.5 times the interquartile range.


Disclosure: T. McGrath, None; J. Guzman, None; L. Tucker, None; N. Shiff, Abbvie, 1, 2, Novartis, 1, 2, Gliead, 1, 2, Mylan, 1, 2; M. Yaskina, None; S. Tupper, None; D. Rumsey, None.

To cite this abstract in AMA style:

McGrath T, Guzman J, Tucker L, Shiff N, Yaskina M, Tupper S, Rumsey D. Consequences and Predictors of Persisting Pain in Children with Juvenile Idiopathic Arthritis: A Case Control Study Nested in the ReACCh-Out Cohort [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 4). https://acrabstracts.org/abstract/consequences-and-predictors-of-persisting-pain-in-children-with-juvenile-idiopathic-arthritis-a-case-control-study-nested-in-the-reacch-out-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2020 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/consequences-and-predictors-of-persisting-pain-in-children-with-juvenile-idiopathic-arthritis-a-case-control-study-nested-in-the-reacch-out-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology